Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
KURA
KURA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
KURA News
Kura Oncology Grants Stock Options to New Employees
4d ago
Newsfilter
Kura Oncology Reports Q4 2025 Earnings with KOMZIFTI Launch Success
5d ago
seekingalpha
Kura Oncology Q4 Earnings Miss Expectations
5d ago
seekingalpha
Kura Oncology Reports Expanded Losses in Q4
5d ago
NASDAQ.COM
Kura Oncology Set to Announce Q4 Earnings on March 5th
6d ago
seekingalpha
Kura Oncology Grants Stock Options to New Employees
Feb 06 2026
Newsfilter
Kura Oncology Reports $2.1M KOMZIFTI Revenue in 2025 Financial Results
Jan 12 2026
NASDAQ.COM
Kura Oncology Launches KOMZIFTI, First Once-Daily Oral Menin Inhibitor with $2.1M Initial Revenue
Jan 11 2026
Globenewswire
Kura Oncology Launches KOMZIFTI, First Once-Daily Oral Menin Inhibitor with $2.1M Initial Revenue
Jan 11 2026
Yahoo Finance
Kura Oncology Gains Ground After Jim Cramer's Remarks
Dec 22 2025
SeekingAlpha
After-Hours Gains on Friday: Biotech and Genomics Stocks Demonstrate Resilience
Dec 22 2025
NASDAQ.COM
Kura Oncology Reports 86% CR Rate for KOMZIFTI in AML Treatment
Dec 08 2025
Newsfilter
GT Biopharma Completes Safety Review for GTB-3650 Phase 1 Trial
Dec 04 2025
Newsfilter
GT Biopharma Completes Safety Review for GTB-3650 Phase 1 Trial
Dec 04 2025
PRnewswire
Kura Receives $135 Million Milestone Payment Following First U.S. Commercial Sale of KOMZIFTI
Dec 03 2025
NASDAQ.COM
Kura Oncology Completes First U.S. Sale of KOMZIFTI, Triggering $135 Million Payment
Dec 02 2025
Globenewswire
Show More News
